A 23-year-old white woman with a history of intravenous drug abuse presented to the emergency department with decreased level of consciousness, chest discomfort, and shortness of breath. Blood work showed anemia (hemoglobin, 7.6 g/dL), thrombocytopenia (platelet count, 69 000/mL), and evidence of hemolysis as reflected by elevated lactate dehydrogenase, undetectable haptoglobin, and brisk reticulocyte response. Iron indices, B 12 , and folate were within normal limits. A peripheral smear indicated microangiopathic hemolysis with red blood cell fragmentation (schistocytes and helmet cells, arrow). The patient had been abusing Opana ER 30 mg tablets by crushing and self-injecting up to 8 times daily. She was started on plasma exchange for a thrombotic thrombocytopenic purpura-like syndrome, and her hematological parameters normalized after 1 week of therapy. No evidence of concomitant infection was found. Interestingly the patient maintained normal creatinine and a disintegrin and metalloproteinase with thrombospondin motif 13 (ADAMTS13) activity.
